Brief: Ensysce Biosciences Regains Compliance With Nasdaq
28/05/2024 13:37
May 28 (Reuters) - Ensysce Biosciences Inc ENSC.O :
* ENSYSCE BIOSCIENCES INC -ENSYSCE BIOSCIENCES REGAINS
COMPLIANCE
WITH NASDAQ
Source text for Eikon: ID:n0001493152-24-021456
Further company coverage: ENSC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ensysce Biosciences
See all newsEnsysce Biosciences Q2 net loss widens on higher R&D costs
Ensysce Biosciences Inc expected to post a loss of 50 cents a share - Earnings Preview
NASDAQ RESUMED AT 09:47 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:42 AM
Brief: Ensysce Biosciences Launches Formal Review Of Strategic Alternatives - SEC Filing